Pharmaceutical Technology

SEPTEMBER 29, 2022

The mRNA-1273.222 vaccine comprises 25µg doses of mRNA-1273 (Spikevax) and a vaccine candidate against the BA.4/BA.5 Moderna has so far obtained authorisations for Omicron-targeting bivalent booster vaccine in the US, Canada, Europe, Australia, South Korea, Switzerland, Japan, Singapore, Taiwan and the UK.

Vaccines 59

Vaccines 59

pharmaphorum

JUNE 6, 2022

With vaccine hesitancy leading to a rise in measles cases, the FDA’s approval of GlaxoSmithKline’s venerable vaccine Priorix for sale in the US looks timely. The post FDA clears GSK’s Priorix, first new MMR vaccine in 50 years appeared first on. Photo credit: CDC/Dr Heinz F Eichenwald via Wikipedia.

Vaccines 59

Vaccines FDA 59

Pharmaceutical Technology

FEBRUARY 3, 2023

Only a few weeks into the new year, the prospect of getting a successful advanced HIV vaccine shrank after the discontinuation of yet another late-stage trial. On January 18, Janssen, a Johnson & Johnson (J&J) subsidiary, stated that its vaccine was not effective in preventing HIV infections.

Vaccines 117

Vaccines Immunization 117

Pharmaceutical Technology

MAY 11, 2023

Results published in Nature for a personalised pancreatic cancer vaccine that uses neoantigens from patients’ tumours have lent further support to early positive signals. The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later.

Vaccines 138

Vaccines Immunization 138

pharmaphorum

OCTOBER 7, 2021

The WHO has given a green light to widespread use of GlaxoSmithKline’s malaria vaccine in Africa, in what could be a major turning point in the fight against the disease. The vaccine could soon be available – as an additional malaria control tool – to more children across Africa. link] #VaccinesWork.

Vaccines 98

Vaccines Hospitals 98

European Pharmaceutical Review

DECEMBER 19, 2023

Many of today’s vaccines are produced in ready-to-inject liquid formulations that must be kept cold to maintain stability. However, this greatly complicates both the worldwide distribution and stockpiling of vaccines and other drugs. A requisite cold chain has been designed and implemented to be uninterrupted from factory to patient.

Vaccines 111

Vaccines Communication Immunization Documentation 111

pharmaphorum

DECEMBER 14, 2022

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna. The vaccine primes the immune system to attack the tumour cells, while Keytruda blocks an immunological ‘brake’ that protects the cancer.

Vaccines 98

Vaccines Immunization 98

pharmaphorum

JULY 30, 2021

Takeda has decided development of its norovirus vaccine candidate outside Japan will be more efficient if it is spun out into a dedicated company. In 2016, the drugmaker spun out a 25-strong team of UK researchers – focused on neurological and psychiatric disorders – into a new company called Cerevance.

Vaccines 52

Vaccines 52

pharmaphorum

FEBRUARY 19, 2021

A global emergency stockpile of Ebola vaccine is being deployed to curb the epidemic, although experts are confident that synergies in public health practises will ensure a rapid response to both. During the 2014-2016 Ebola outbreak, Guinea was one of the worst impacted countries and saw more than 2,543 deaths. “Our

Vaccines 64

Vaccines FDA 64

pharmaphorum

MAY 26, 2021

The government’s last attempt to shake up patient data-sharing – 2013’s Care.data scheme – suffered from a number of false starts and was eventually shut down in 2016. Its demise came after the Caldicott review into safeguards found issues with consent and opt-out processes.

Communication 116

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 116

European Pharmaceutical Review

APRIL 26, 2023

Built to deliver Moderna’s ten-year strategic partnership with the UK government, announced in March 2023, the MITC will incorporate research, development and a manufacturing facility for mRNA vaccines. Its Health Tech cluster has grown to over 70 life science organisations since its launch in 2016. Credit: Tom Weller Photography. (L-R)

Vaccines 52

Vaccines 52

PharmaShots

MAY 23, 2023

Stock Exchange: TYO With focus areas extending to the discovery and development of biopharma products, AnGes is dedicated to developing genetic medicines and therapeutic vaccines for intractable or rare diseases. Approved Cell and Gene Therapy: Collategene Founded Year: 1999 Total Employees: ~140 Headquarters: Osaka, Japan Market Cap: $162.8M

FDA 58

FDA Pharmaceutical Companies Pharmaceutical Companies Immunization 58

Pharmaceutical Technology

SEPTEMBER 5, 2022

Following AstraZeneca’s success in vaccine development during the Covid-19 pandemic , the pharmaceutical giant is now looking to expand its scope through acquisitions across a range of indications, says CEO Pascal Soriot. “We Between 1 May 2016 and 31 May 2021, the FDA approved 207 drugs for cancer and malignant haematology.

FDA 114

FDA Vaccines 114

pharmaphorum

FEBRUARY 23, 2022

The global health crisis caused spending on healthcare to increase , due to the funding provided to the development and purchases of vaccines and treatments, as well as support provided for the associated infrastructure. billion in 2020.

Vaccines 98

Vaccines FDA 98

ISPE

OCTOBER 25, 2022

Throughout her early career, she successfully led multiple biotech, vaccine, and API processes from late-stage research and development to clinical and commercial manufacturing. The project won an ISPE Facility of the Year Award (FOYA) for Process Innovation and was the overall FOYA winner for 2016.

Vaccines 98

Vaccines 98

The Checkup by Singlecare

JULY 11, 2024

Prednisolone ( Prednisolone is the active form, whereas prednisone has to be converted to prednisolone by the liver before it can work) , a powerful anti-inflammatory medication, has been shown effective as a first-line treatment for gout in studies such as those from 2016 and 2017. It might work quickly, too.

Dosage 94

Dosage Packaging Immunization FDA 94

pharmaphorum

APRIL 11, 2022

Medicines and vaccines are among the most powerful interventions that can help improve quality of life for people across the world. At Janssen, we strive to improve access to our innovative medicines and vaccines and achieve the best possible outcomes for patients across the world.

Pharmaceutical Companies 115

Pharmaceutical Companies Pharmaceutical Companies Vaccines Packaging 115

pharmaphorum

JANUARY 29, 2023

Think about recent technological breakthroughs such as mRNA vaccines and the potential for mRNA-based therapeutics, or the recent ramp up in vaccine production facilities – to name just a few examples. Attracted by healthcare’s steady and rising revenues, financial investors made 55% of 2022’s acquisitions, up from 43% in 2016.

Nursing Homes 98

Nursing Homes Hospitals Vaccines 98

European Pharmaceutical Review

JULY 20, 2022

Our research looked at products that were voluntarily withdrawn, or had their licence revoked or suspended within the EU for a safety reason between 2012 and 2016. Researchers also study the long-term effects of medicines and vaccines, as well as the safety of new and advanced products. Study focus. almitrine – a respiratory stimulant.

Adverse Reactions 97

Adverse Reactions Hospitals Vaccines 97

pharmaphorum

SEPTEMBER 27, 2021

As the vaccines were developed and rolled out, the disparity in their take up among different sections of the community highlighted how excluded some minority communities felt from areas of healthcare. Vaccine hesitancy was the most recent and highest profile example of distrust among minority groups towards the pharmaceutical industry.

Vaccines 122

Vaccines Communication FDA 122

pharmaphorum

SEPTEMBER 18, 2020

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle in business development elsewhere, signing back-to-back deals with Vertex and Chiesi that have brought in $100 million upfront. .

Vaccines 105

Vaccines 105

The Checkup by Singlecare

MAY 16, 2024

You should not get live vaccines during treatment with Remicade, and other vaccines may be less effective. Inflectra Approved by the FDA in 2016, Inflectra (infliximab-dyyb) was the first biosimilar to Remicade. There’s also a risk of cancer, like lymphoma, in children.

FDA 98

FDA Immunization Labelling Vaccines 98

Pharmaceutical Technology

JUNE 27, 2022

As part of the symposium, Dr Graham Foster, who was appointed National Clinical Chair for the Hepatitis C Delivery Network in January 2016, shed light on hepatitis C care strategies in England. She says this could involve using family health care facilities where children also receive their vaccines.

Vaccines 105

Vaccines 105

Blog: Ask a Student Pharmacist

AUGUST 23, 2023

In : Lyophilized Biologics and Vaccines: Modality-Based Approaches. 25-42 E Shalaev , AK Soper (2016). 6b06157 E Shalaev , K Wu, S Shamblin, JF Krzyzaniak, M Descamps (2016). D Varshney, M Singh (Eds), Springer, pp. Water in a Soft Confinement: Structure of Water in Amorphous Sorbitol. J Phys Chem B, DOI: 10.1021/acs.jpcb.6b06157

Dosage 52

Dosage Vaccines 52

PQA

NOVEMBER 16, 2023

Here are the PQA Executive Fellowship alumni and where they are today: Laurin Dixon, PharmD, Lead Executive, Medicare Products, Arkansas Blue Cross and Blue Shield (2013-2014 Executive Fellow) Maria Scarlatos Eid, PharmD, CPHQ, Global Professional Relations & Independent Medical Education, Vaccines, Merck (2014-2015 Executive Fellow) Hannah (..)

Vaccines 45

Vaccines 45

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 This resulted in AstraZeneca becoming possibly the most talked-about pharma company in the world when its own vaccine emerged as the frontrunning candidate. Pfizer makes its move.

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 116

pharmaphorum

JANUARY 21, 2022

And as with many healthcare challenges, it is an issue that has been brought into sharp focus by COVID-19, during which we have seen huge investments in ground-breaking vaccines, quickly followed by inequities in access. By 2016, Gilead already had competition for the HCV market, when MSD launched their product at €47,000 per treatment.

Insurance 52

Insurance Vaccines 52

European Pharmaceutical Review

FEBRUARY 3, 2023

Compared to other leading EU countries (Italy, Spain, Germany, France), the UK has experienced the largest decline in its global share of new medicine launches between 2016-2021. The ABPI emphasised that recent Government policy has led to disinvestment in medicines through the cap on growth for a decade.

Vaccines 59

Vaccines 59

Roots Analysis

MARCH 28, 2022

There has been a significant increase in the number of expansions in order to adopt continuous manufacturing since 2016. You may also be interested in the following titles: Single-Use Upstream Bioprocessing Technology Pharmaceutical Secondary Packaging Market Viral Vaccine Cell Culture Media Market Distribution. Web: [link].

Packaging 52

Packaging Dosage Vaccines 52

pharmaphorum

SEPTEMBER 22, 2021

Texas-based Abexxa has been on the Boehringer’s radar since it was set up, as it provided seed funding for the preclinical-stage company in 2016, buying into its approach of developing antibodies against targets inside cancer cells, rather than on the cell membrane. Last December, Boehringer paid €1.8

Vaccines 92

Vaccines Immunization 92

Roots Analysis

FEBRUARY 26, 2024

Given the robust pipeline of biologics, which include monoclonal antibodies, vaccines and other protein-based therapeutic products, subcutaneous medications are being investigated for various clinical candidates across different phases of development.

Medication Delivery 52

Medication Delivery Pharmaceutical Companies Pharmaceutical Companies Vaccines 52

The FDA Law Blog

APRIL 7, 2025

Zenrelia comes with serious warnings, including a boxed warning against the use of Zenrelia during vaccination. CVM also objected to the truncation of other information about the timing of vaccines in these promotional materials. Zenrelia promotional materials also included claims about clinical data that the Agency found actionable.

Vaccines 64

Vaccines FDA Adverse Reactions 64

Roots Analysis

AUGUST 1, 2023

With their impressive capability to quickly transport essential medications, vaccines , and even organs, medical drones have become indispensable in the mission to save lives. It’s worth noting that since 2016, a substantial investment of over USD 3 billion has already been made in this field, driving innovation and progress.

Vaccines 52

Vaccines 52

Hospital Pharmacy Europe

NOVEMBER 23, 2023

Similar findings were observed in previous iterations of the survey in 2016, 2017/18 and 2018/19. However, among other countries, the most common reason for a negative answer was limited capacity (30%), followed by it not being considered a priority by managers (21%) and having limited capability despite wanting to achieve it (14%).

Hospitals 52

Hospitals Compounding Patient Care Vaccines 52

ISPE

OCTOBER 26, 2022

ATMP facilities are different from conventional pharmaceutical facilities that process other traditional modalities, such as vaccines and monoclonal antibodies (mAbs), and often require heightened segregation and smaller footprints. Viral antigen vaccines. For example: Live vaccine manufacturing. Complete Data Gathering.

Vaccines 97

Vaccines Compounding Documentation FDA 97

The Checkup by Singlecare

DECEMBER 26, 2023

You can also get a vaccine called Shingrix to help reduce the risk of shingles infection if you are 50 or older—or if you are 19 or older with a higher risk of infection. Treatment for shingles may include oral antiviral medication as well as comfort measures like a moist, cold compress over the eyes.

Immunization 52

Immunization Vaccines 52

Pharmaceutical Technology

JUNE 30, 2022

In Muratov’s opinion, this was reflective of a wider pattern seen in almost any other field of research, which could now change with the development of Covid-19 vaccines and antivirals. Acoziborole was previously discovered by the company Anacor Pharmaceuticals, which Pfizer acquired in 2016. Covid-19 had other knock-on effects.

Vaccines 64

Vaccines FDA Hospitals 64